These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29410326)

  • 21. Severe community-acquired pneumonia: an Australian perspective.
    Wilson PA; Ferguson J
    Intern Med J; 2005 Dec; 35(12):699-705. PubMed ID: 16313544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
    Tamm M; Todisco T; Feldman C; Garbino J; Blasi F; Hogan P; de Caprariis PJ; Hoepelman IM
    Clin Microbiol Infect; 2007 Feb; 13(2):162-171. PubMed ID: 17328728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
    Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
    Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Macrolide Deescalation in Severe Community-acquired Pneumonia.
    Hopkins TM; Juang P; Weaver K; Kollef MH; Betthauser KD
    Clin Ther; 2019 Dec; 41(12):2540-2548. PubMed ID: 31676040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotics for community-acquired pneumonia in children.
    Lodha R; Kabra SK; Pandey RM
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD004874. PubMed ID: 23733365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis.
    Arancibia F; Bauer TT; Ewig S; Mensa J; Gonzalez J; Niederman MS; Torres A
    Arch Intern Med; 2002 Sep; 162(16):1849-58. PubMed ID: 12196083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial treatment failure in non-ICU community-acquired pneumonia: risk factors and association with length of stay, total hospital charges, and mortality.
    Oster G; Berger A; Edelsberg J; Weber DJ
    J Med Econ; 2013; 16(6):809-19. PubMed ID: 23574431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Program of empirical antibacterial therapy of community-acquired pneumonia].
    Suvorova MP; Iakovlev SV; Shakhova TV; Dvoretskiĭ LI
    Antibiot Khimioter; 1998; 43(7):31-5. PubMed ID: 9727165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of late-onset hospital-acquired pneumonia related to causative organism.
    McClure JR; Cooke RP; Lal P; Pickles D; Majjid S; Grant CA; Jones TM; Dempsey GA
    J Hosp Infect; 2009 Apr; 71(4):348-52. PubMed ID: 19157643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia.
    Teh B; Grayson ML; Johnson PD; Charles PG
    Clin Microbiol Infect; 2012 Apr; 18(4):E71-3. PubMed ID: 22284533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Narrow-spectrum ß-lactam monotherapy in hospital treatment of community-acquired pneumonia: a register-based cohort study.
    Rhedin S; Galanis I; Granath F; Ternhag A; Hedlund J; Spindler C; Naucler P
    Clin Microbiol Infect; 2017 Apr; 23(4):247-252. PubMed ID: 28017793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viruses and Gram-negative bacilli dominate the etiology of community-acquired pneumonia in Indonesia, a cohort study.
    Farida H; Gasem MH; Suryanto A; Keuter M; Zulkarnain N; Satoto B; van der Eijk AA; Djokomoeljanto R; Wahyono H; Verbrugh HA; Severin JA; van den Broek PJ
    Int J Infect Dis; 2015 Sep; 38():101-7. PubMed ID: 26255889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
    Querol-Ribelles JM; Tenías JM; Querol-Borrás JM; Labrador T; Nieto A; González-Granda D; Martínez I
    Int J Antimicrob Agents; 2005 Jan; 25(1):75-83. PubMed ID: 15620830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of an antimicrobial stewardship program on outcomes in patients with community-acquired pneumonia admitted to a tertiary community hospital.
    Gordon K; Stevens R; Westley B; Bulkow L
    Am J Health Syst Pharm; 2018 Jun; 75(11 Supplement 2):S42-S50. PubMed ID: 29802178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriologic profile and susceptibility pattern of mechanically ventilated paediatric patients with pneumonia.
    El-Nawawy A; Ramadan MA; Antonios MA; Arafa SA; Hamza E
    J Glob Antimicrob Resist; 2019 Sep; 18():88-94. PubMed ID: 30710648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial pathogens of adult community-acquired pneumonia in Southern Estonia.
    Leesik H; Ani U; Juhani A; Altraja A
    Medicina (Kaunas); 2006; 42(5):384-94. PubMed ID: 16778466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A; Pugh J
    Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children.
    Smith MJ; Kong M; Cambon A; Woods CR
    Pediatrics; 2012 May; 129(5):e1326-33. PubMed ID: 22492769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.